Back to top

Analyst Blog

A recent client win by MedAssets, Inc. (MDAS - Snapshot Report) should help further propel investor confidence in the stock. On a year-to-date basis, the company has returned an impressive 40.7% to its investors.

Riverdale, Ga.-based Southern Regional Medical Center (“SRMC”) has entered into an agreement with MedAssets to improve its operating as well as financial performance. The hospital will be using MDAS’ Accounts Receivable (A/R) Services and revenue cycle consulting expertise to manage aged receivables and liquidate cash more efficiently.

As per the agreement, SRMC will engage MedAssets A/R Services to maintain as well as enhance its net cash collections, as it installs a new fully integrated revenue cycle platform, including an electronic health record and physician order entry modules. SRMC will outsource its aged receivables management to MDAS, on an ongoing basis, so that management can fully focus on implementation and training for the new system.

MedAssets provides web-based workflow technology that helps mitigate increasing financial pressures faced by hospitals, health systems, and other non-acute healthcare providers. Management asserts that its full suite of solutions is capable of improving client operating margins by 1.5%-5.0% by increasing revenue capture, reducing supply costs and improving clinical resource utilization. The company’s client-base boasts over 4,200 acute care hospitals and more than 122,000 ancillary or non-acute provider locations.

Earlier, The Texas Purchasing Coalition (TPC) renewed its performance management relationship with MDAS. The contract extension builds on the former’s success in realizing more than $90 million in documented savings since 2010.

Currently, MedAssets has a Zacks Rank #3 (Hold). While we choose to remain on the sidelines regarding MDAS, other better-performing medical services stocks include Omnicare Inc. (OCR - Snapshot Report), Covance Inc. (CVD - Analyst Report) and Quintiles Transnational Holdings Inc. (Q - Snapshot Report). All these stocks carry a Zacks Rank #2 (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.00 +3.09%
SANCHEZ ENE… SN 34.18 +2.67%
THE PANTRY… PTRY 21.02 +2.09%
INTEL CP INTC 35.15 +1.88%
PIPER JAFFR… PJC 54.54 +1.70%